Investor-rights firm said it is preparing a potential securities class action after short seller Pelican Way Research alleged Blaize's recent $50 million NeoTensr deal was fraudulent.
Rosen Law Firm said it is investigating potential securities claims on behalf of shareholders of Blaize Holdings, Inc. over allegations that the company may have issued materially misleading business information to investors. The notice cites an April 28, 2026 Investing.com article reporting that Blaize shares fell after short seller Pelican Way Research alleged the company’s recent $50 million deal with NeoTensr was fraudulent. Blaize stock fell 12% on April 28, 2026, according to the release. Rosen said it is preparing a securities class action to recover investor losses and told purchasers of Blaize securities they may be entitled to compensation through a contingency fee arrangement.